CHE insider transaction filings
CHEMED CORP — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-21. Screen CHE transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 7 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings by 3 insiders — 7,190 shares, $3,806,260 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 2,000 shares @ $541.16 ($1,082,320) by MCNAMARA KEVIN J, filed 2026-08-24.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| MCNAMARA KEVIN J — president and CEO, Director | 3 | — | 3 legs · 6,000 sh · $3,164,140 | 3 |
| LEE SPENCER S — executive vice president | 1 | — | 1 leg · 1,000 sh · $541,040 | — |
| GRACE PATRICK P — Director | 1 | — | 1 leg · 190 sh · $101,080 | — |
| Judkins Brian C — VP and Chief Legal Officer | 1 | — | — | 3 |
| Wherley Joel L — CEO - Vitas Healthcare | 1 | — | — | 3 |
Recent Form 4 filings — CHEMED CORP
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-21 | 4 | MCNAMARA KEVIN J — president and CEO, Director | Sale (S): 2,000 @ $501.40 | EDGAR |
| 2026-08-24 | 4 | LEE SPENCER S — executive vice president | Sale (S): 1,000 @ $541.04 | EDGAR |
| 2026-08-24 | 4 | MCNAMARA KEVIN J — president and CEO, Director | Sale (S): 2,000 @ $541.16 | EDGAR |
| 2026-08-10 | 4 | Judkins Brian C — VP and Chief Legal Officer | Option exercise (M): 6,786 @ $445.35 · Tax withholding (F): 5,878 @ $548.96 · Option exercise (M): 6,786 (derivative) @ $445.35 | EDGAR |
| 2026-08-06 | 4 | Wherley Joel L — CEO - Vitas Healthcare | Option exercise (M): 2,599 @ $445.35 · Tax withholding (F): 2,270 @ $542.62 · Option exercise (M): 2,599 (derivative) @ $445.35 | EDGAR |
| 2026-08-04 | 4 | MCNAMARA KEVIN J — president and CEO, Director | Option exercise (M): 2,001 @ $445.35 · Tax withholding (F): 19,802 @ $529.22 · Sale (S): 2,000 @ $539.51 · Option exercise (M): 2,001 (derivative) @ $445.35 | EDGAR |
| 2026-08-03 | 4 | GRACE PATRICK P — Director | Sale (S): 190 @ $532 | EDGAR |
| 2026-06-10 | 4 | LINDELL ANDREA R — Director | Sale (S): 1,347 @ $447.33 | EDGAR |
| 2026-05-29 | 4 | WALSH GEORGE J III — Director | Sale (S): 500 @ $437.83 | EDGAR |
| 2026-05-19 | 4 | McCarthy Eileen P — Director | Grant/award (A): 386 @ $440.77 | EDGAR |
| 2026-05-19 | 4 | Mount John Meredith Jr. — Director | Grant/award (A): 386 @ $440.77 | EDGAR |
| 2026-05-19 | 4 | Heaney Christopher J — Director | Grant/award (A): 386 @ $440.77 | EDGAR |
| 2026-05-19 | 4 | DeLyons Ron — Director | Grant/award (A): 386 @ $440.77 | EDGAR |
| 2026-05-19 | 4 | GRACE PATRICK P — Director | Grant/award (A): 386 @ $440.77 | EDGAR |
| 2026-05-19 | 4 | LINDELL ANDREA R — Director | Grant/award (A): 386 @ $440.77 | EDGAR |
| 2026-05-19 | 4 | WALSH GEORGE J III — Director | Grant/award (A): 386 @ $440.77 | EDGAR |
| 2026-05-08 | 4 | GRACE PATRICK P — Director | Sale (S): 60 @ $425.78 | EDGAR |
| 2026-05-04 | 4 | MCNAMARA KEVIN J — president and CEO, Director | Sale (S): 2,000 @ $421.13 | EDGAR |
| 2026-03-30 | 4 | MCNAMARA KEVIN J — president and CEO, Director | Sale (S): 1,500 @ $369.37 | EDGAR |
| 2026-03-13 | 4 | MCNAMARA KEVIN J — president and CEO, Director | Sale (S): 2,000 @ $403.18 | EDGAR |
| 2026-02-17 | 4 | Wherley Joel L — CEO - Vitas Healthcare | Option exercise (M): 273 @ $469.56 · Option exercise (M): 0 @ $469.56 · Tax withholding (F): 80 @ $469.56 · Option exercise (M): 220 (derivative) @ $0 · Option exercise (M): 220 (derivative) @ $0 · Grant/award (A): 1,142 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Judkins Brian C — VP and Chief Legal Officer | Option exercise (M): 351 @ $469.56 · Option exercise (M): 0 @ $469.56 · Tax withholding (F): 102 @ $469.56 · Option exercise (M): 283 (derivative) @ $0 · Option exercise (M): 283 (derivative) @ $0 · Grant/award (A): 908 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Witzeman Michael D — VP & Chief Financial Officer | Option exercise (M): 413 @ $469.56 · Option exercise (M): 0 @ $469.56 · Tax withholding (F): 120 @ $469.56 · Option exercise (M): 333 (derivative) @ $0 · Option exercise (M): 333 (derivative) @ $0 · Grant/award (A): 1,394 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | MCNAMARA KEVIN J — president and CEO, Director | Option exercise (M): 2,714 @ $469.56 · Option exercise (M): 0 @ $469.56 · Tax withholding (F): 1,192 @ $469.56 · Option exercise (M): 2,187 (derivative) @ $0 · Option exercise (M): 2,187 (derivative) @ $0 · Grant/award (A): 5,114 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | LEE SPENCER S — executive vice president | Option exercise (M): 499 @ $469.56 · Option exercise (M): 0 @ $469.56 · Tax withholding (F): 154 @ $469.56 · Option exercise (M): 402 (derivative) @ $0 · Option exercise (M): 402 (derivative) @ $0 · Grant/award (A): 960 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | HUTTON THOMAS C — vice president, Director | Option exercise (M): 199 @ $469.56 · Option exercise (M): 0 @ $469.56 · Tax withholding (F): 72 @ $469.56 · Option exercise (M): 160 (derivative) @ $0 · Option exercise (M): 160 (derivative) @ $0 · Grant/award (A): 374 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | LINDELL ANDREA R — Director | Gift (G): 463 @ $0 | EDGAR |
| 2025-11-25 | 4 | MCNAMARA KEVIN J — president and CEO, Director | Sale (S): 2,000 @ $437.55 | EDGAR |
| 2025-11-19 | 4 | LEE SPENCER S — executive vice president | Gift (G): 60 @ $0 | EDGAR |
| 2025-10-22 | 4 | Wherley Joel L — CEO - Vitas Healthcare | Grant/award (A): 17,476 (derivative) @ $443.79 | EDGAR |
| 2025-10-22 | 4 | Judkins Brian C — VP and Chief Legal Officer | Grant/award (A): 15,017 (derivative) @ $443.79 | EDGAR |
| 2025-10-22 | 4 | Witzeman Michael D — VP & Chief Financial Officer | Grant/award (A): 19,486 (derivative) @ $443.79 | EDGAR |
| 2025-10-22 | 4 | MCNAMARA KEVIN J — president and CEO, Director | Grant/award (A): 58,672 (derivative) @ $443.79 | EDGAR |
| 2025-10-22 | 4 | LEE SPENCER S — executive vice president | Grant/award (A): 12,759 (derivative) @ $443.79 | EDGAR |
| 2025-10-22 | 4 | HUTTON THOMAS C — vice president, Director | Grant/award (A): 6,338 (derivative) @ $443.79 | EDGAR |
| 2025-09-29 | 4 | MCNAMARA KEVIN J — president and CEO, Director | Sale (S): 3,000 @ $461.28 | EDGAR |
| 2025-09-10 | 4 | GRACE PATRICK P — Director | Sale (S): 150 @ $463.39 | EDGAR |
| 2025-08-05 | 4 | Westfall Nicholas Michael — Executive Vice President | Sale (S): 10,012 @ $421.91 | EDGAR |
| 2025-08-05 | 4 | WALSH GEORGE J III — Director | Purchase (P): 200 @ $417.10 | EDGAR |
| 2025-08-05 | 4 | MCNAMARA KEVIN J — president and CEO, Director | Sale (S): 2,000 @ $428.55 | EDGAR |
| 2025-05-20 | 4 | McCarthy Eileen P — Director | Grant/award (A): 277 @ $579.04 | EDGAR |
| 2025-05-20 | 4 | Mount John Meredith Jr. — Director | Grant/award (A): 277 @ $579.04 | EDGAR |
| 2025-05-20 | 4 | Heaney Christopher J — Director | Grant/award (A): 277 @ $579.04 | EDGAR |
| 2025-05-20 | 4 | DeLyons Ron — Director | Grant/award (A): 277 @ $579.04 | EDGAR |
| 2025-05-20 | 4 | GRACE PATRICK P — Director | Grant/award (A): 277 @ $579.04 | EDGAR |
| 2025-05-20 | 4 | LINDELL ANDREA R — Director | Grant/award (A): 277 @ $579.04 | EDGAR |
| 2025-05-20 | 4 | WALSH GEORGE J III — Director | Grant/award (A): 277 @ $579.04 | EDGAR |
| 2025-05-19 | 4 | LEE SPENCER S — executive vice president | Sale (S): 1,500 @ $577.99 | EDGAR |
| 2025-05-12 | 4 | Westfall Nicholas Michael — Executive Vice President | Option exercise (M): 16,132 @ $445.35 · Option exercise (M): 9,956 @ $462.04 · Tax withholding (F): 23,000 @ $569.70 · Option exercise (M): 16,132 (derivative) @ $445.35 · Option exercise (M): 9,956 (derivative) @ $462.04 | EDGAR |
| 2025-05-08 | 4 | LEE SPENCER S — executive vice president | Sale (S): 1,500 @ $577.86 | EDGAR |
Recent 8-K events — CHEMED CORP
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-25 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-27 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-20 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-04-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CHE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →